Drugs / GRm13Z40-2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01082926 | May 2010 → Sep 2013 | anaplastic astrocytoma, anaplastic ependymoma, anaplastic meningioma, anaplastic oligodendroglioma +7 | City of Hope Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRm13Z40-2 | “Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified” NCT01082926 ↗ |
| Modality | Cell therapy | “cellular adoptive immunotherapy” NCT01082926 ↗ |
| Route | Other | “therapeutic allogeneic lymphocytes intratumorally” NCT01082926 ↗ |